Wolverine Trading
AVDL

Wolverine Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Wolverine Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,400
Closed -$91.3K – 4718
2025
Q1 		$91.3K Buy
+11,400
New +$95.5K ﹤0.01% 4255
2024
Q4 		– Sell
-10,500
Closed -$134K – 5236
2024
Q3 		$134K Buy
+10,500
New +$160K ﹤0.01% 4258
2024
Q1 		– Sell
-17,300
Closed -$244K – 4475
2023
Q4 		$244K Buy
17,300
+2,000
+13% +$23.5K ﹤0.01% 3675
2023
Q3 		$158K Sell
15,300
-8,900
-37% -$119K ﹤0.01% 3842
2023
Q2 		$359K Buy
+24,200
New +$315K ﹤0.01% 2915
2022
Q2 		– Sell
-11,000
Closed -$77K – 4477
2022
Q1 		$77K Buy
+11,000
New +$75.6K ﹤0.01% 4924
2021
Q3 		– Sell
-16,900
Closed -$118K – 6233
2021
Q2 		$118K Buy
16,900
+600
+4% +$4.76K ﹤0.01% 5321
2021
Q1 		$145K Sell
16,300
-7,400
-31% -$59.8K ﹤0.01% 5258
2020
Q4 		$159K Buy
+23,700
New +$148K ﹤0.01% 4337
2020
Q2 		– Sell
-44,800
Closed -$391K – 4554
2020
Q1 		$391K Buy
+44,800
New +$344K ﹤0.01% 2924
2019
Q4 		– Sell
-22,800
Closed -$97K – 4630
2019
Q3 		$97K Buy
22,800
+12,300
+117% +$30.8K ﹤0.01% 3853
2019
Q2 		$30K Buy
+10,500
New +$18K ﹤0.01% 4259
2018
Q3 		– Sell
-10,600
Closed -$77K – 4902
2018
Q2 		$77K Hold
10,600
– – ﹤0.01% 4812
2018
Q1 		$77K Buy
+10,600
New +$93.2K ﹤0.01% 4812
2016
Q3 		– Sell
-17,700
Closed -$191K – 4576
2016
Q2 		$191K Buy
+17,700
New +$189K ﹤0.01% 3314

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Wolverine Trading's AVDL Position: Q1 2024 in Review

Wolverine Trading sold out of Avadel Pharmaceuticals (AVDL) in Q1 2024, closing a stake of 20,776 shares — an estimated $293K sold.

Wolverine Trading first reported a position in AVDL in Q4 2017 and held it in 9 quarters. The position peaked at $293K in Q4 2023. 127 funds tracked by Wall St. Rank hold AVDL as of Q1 2024.

  • Wolverine Trading reported no remaining Avadel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Wolverine Trading sold 20,776 Avadel Pharmaceuticals shares in Q1 2024, an estimated $293K.
  • Wolverine Trading first reported a position in Avadel Pharmaceuticals in Q4 2017 and held it in 9 quarters.
  • Wolverine Trading's Avadel Pharmaceuticals position peaked at $293K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2024.

Based on Wolverine Trading's 13F filing for Q1 2024, filed 15 May 2024.